Beadle B M, McGovern S L, Patera A, Shoichet B K
Department of Molecular Pharmacology & Biological Chemistry, Northwestern University, Chicago, Illinois 60611-3008, USA.
Protein Sci. 1999 Sep;8(9):1816-24. doi: 10.1110/ps.8.9.1816.
Despite decades of intense study, the complementarity of beta-lactams for beta-lactamases and penicillin binding proteins is poorly understood. For most of these enzymes, beta-lactam binding involves rapid formation of a covalent intermediate. This makes measuring the equilibrium between bound and free beta-lactam difficult, effectively precluding measurement of the interaction energy between the ligand and the enzyme. Here, we explore the energetic complementarity of beta-lactams for the beta-lactamase AmpC through reversible denaturation of adducts of the enzyme with beta-lactams. AmpC from Escherichia coli was reversibly denatured by temperature in a two-state manner with a temperature of melting (Tm) of 54.6 degrees C and a van't Hoff enthalpy of unfolding (deltaH(VH)) of 182 kcal/mol. Solvent denaturation gave a Gibbs free energy of unfolding in the absence of denaturant (deltaG(u)H2O) of 14.0 kcal/mol. Ligand binding perturbed the stability of the enzyme. The penicillin cloxacillin stabilized AmpC by 3.2 kcal/mol (deltaTm = +5.8 degrees C); the monobactam aztreonam stabilized the enzyme by 2.7 kcal/mol (deltaTm = +4.9 degrees C). Both acylating inhibitors complement the active site. Surprisingly, the oxacephem moxalactam and the carbapenem imipenem both destabilized AmpC, by 1.8 kcal/mol (deltaTm = -3.2 degrees C) and 0.7 kcal/mol (deltaTm = -1.2 degrees C), respectively. These beta-lactams, which share nonhydrogen substituents in the 6(7)alpha position of the beta-lactam ring, make unfavorable noncovalent interactions with the enzyme. Complexes of AmpC with transition state analog inhibitors were also reversibly denatured; both benzo(b)thiophene-2-boronic acid (BZBTH2B) and p-nitrophenyl phenylphosphonate (PNPP) stabilized AmpC. Finally, a catalytically inactive mutant of AmpC, Y150F, was reversibly denatured. It was 0.7 kcal/mol (deltaTm = -1.3 degrees C) less stable than wild-type (WT) by thermal denaturation. Both the cloxacillin and the moxalactam adducts with Y150F were significantly destabilized relative to their WT counterparts, suggesting that this residue plays a role in recognizing the acylated intermediate of the beta-lactamase reaction. Reversible denaturation allows for energetic analyses of the complementarity of AmpC for beta-lactams, through ligand binding, and for itself, through residue substitution. Reversible denaturation may be a useful way to study ligand complementarity to other beta-lactam binding proteins as well.
尽管经过数十年的深入研究,但β-内酰胺与β-内酰胺酶及青霉素结合蛋白之间的互补性仍未得到充分理解。对于大多数这类酶而言,β-内酰胺结合涉及共价中间体的快速形成。这使得测量结合态与游离态β-内酰胺之间的平衡变得困难,实际上排除了对配体与酶之间相互作用能的测量。在此,我们通过β-内酰胺与该酶加合物的可逆变性,探索β-内酰胺对β-内酰胺酶AmpC的能量互补性。来自大肠杆菌的AmpC以两态方式随温度可逆变性,解链温度(Tm)为54.6℃,解折叠的范特霍夫焓(ΔH(VH))为182千卡/摩尔。溶剂变性在无变性剂时给出的解折叠吉布斯自由能(ΔG(u)H2O)为14.0千卡/摩尔。配体结合扰乱了酶的稳定性。青霉素氯唑西林使AmpC稳定3.2千卡/摩尔(ΔTm = +5.8℃);单环β-内酰胺氨曲南使该酶稳定2.7千卡/摩尔(ΔTm = +4.9℃)。两种酰化抑制剂均与活性位点互补。令人惊讶的是,氧头孢烯类莫拉西林和碳青霉烯类亚胺培南均使AmpC不稳定,分别为1.8千卡/摩尔(ΔTm = -3.2℃)和0.7千卡/摩尔(ΔTm = -1.2℃)。这些在β-内酰胺环的6(7)α位共享非氢取代基的β-内酰胺与该酶形成不利的非共价相互作用。AmpC与过渡态类似物抑制剂的复合物也可被可逆变性;苯并(b)噻吩-2-硼酸(BZBTH2B)和对硝基苯基苯基膦酸酯(PNPP)均使AmpC稳定。最后,AmpC的催化无活性突变体Y150F可被可逆变性。通过热变性,它比野生型(WT)稳定性低0.7千卡/摩尔(ΔTm = -1.3℃)。与WT对应物相比,Y150F与氯唑西林和莫拉西林的加合物均显著不稳定,这表明该残基在识别β-内酰胺酶反应的酰化中间体中起作用。可逆变性允许通过配体结合对AmpC与β-内酰胺的互补性进行能量分析,并通过残基取代对其自身进行能量分析。可逆变性可能也是研究配体与其他β-内酰胺结合蛋白互补性的一种有用方法。